Supercharged lateral flow tests to detect 10 different diseases

Health
By Liam

British scientists are developing supercharged lateral flow-style tests to detect early signs of up to 10 diseases within minutes.

The point-of-care tests are expected to simultaneously detect disease markers, including cardiovascular disease and some cancers.

Researchers at Oxford and Cambridge say the results will be combined on a smartphone-readable device, similar to a lateral flow test.

EDX Medical Group PLC, the Cambridge-based company behind the technology, also called the rapid tests “game-changing.”

Smartphone camera technology, which will help read and interpret test results, will set new standards for point-of-care clinical testing, the company claimed.

The new, miniaturized “point-of-care” tests are intended to detect disease markers at the same time. Markers that researchers at Oxford and Cambridge are developing include cardiovascular disease and some types of cancer. The results of the numerous “mini-tests” available are combined on a smartphone-readable device, similar to a lateral flow test

The new, miniaturized “point-of-care” tests are intended to detect disease markers at the same time. Markers that researchers at Oxford and Cambridge are developing include cardiovascular disease and some types of cancer. The results of the numerous “mini-tests” available are combined on a smartphone-readable device, similar to a lateral flow test

The smartphone camera technology, which also helps read and interpret test results, will set new standards for point-of-care clinical testing, the company claimed. Point-of-care testing – also called point-of-care testing – typically allows healthcare professionals to perform a test using a device or test kit in the patient's presence without having to send a sample to a laboratory

The smartphone camera technology, which also helps read and interpret test results, will set new standards for point-of-care clinical testing, the company claimed. Point-of-care testing – also called point-of-care testing – typically allows healthcare professionals to perform a test using a device or test kit in the patient's presence without having to send a sample to a laboratory

The smartphone camera technology, which also helps read and interpret test results, will set new standards for point-of-care clinical testing, the company claimed. Point-of-care testing – also called point-of-care testing – typically allows healthcare professionals to perform a test using a device or test kit in the patient’s presence without having to send a sample to a laboratory

This comes as supermarket giant Tesco launched a range of home health tests in March, allowing customers to purchase self-diagnosis kits designed to detect the early warning signs of serious illnesses such as bowel cancer, kidney disease and even flu while they do their weekly shopping. The do-it-yourself checks, available on the company's website and in more than 500 stores nationwide, use the same technology as the lateral flow devices

This comes as supermarket giant Tesco launched a range of home health tests in March, allowing customers to purchase self-diagnosis kits designed to detect the early warning signs of serious illnesses such as bowel cancer, kidney disease and even flu while they do their weekly shopping. The do-it-yourself checks, available on the company's website and in more than 500 stores nationwide, use the same technology as the lateral flow devices

This comes as supermarket giant Tesco launched a range of home health tests in March, allowing customers to purchase self-diagnosis kits designed to detect the early warning signs of serious illnesses such as bowel cancer, kidney disease and even flu, while they have their do weekly shopping. The do-it-yourself checks are available on the company’s website and in more than 500 stores nationwide and use the same technology as the lateral flow devices

Point-of-care testing – also called point-of-care testing – typically allows healthcare professionals to perform a test using a device or test kit in the patient’s presence without having to send a sample to a laboratory.

The move follows EDX Medical’s acquisition of Oxford-based Hutano Diagnostics Ltd, which will see scientists in both cities work to accelerate the reach of the new tests.

Cardiovascular disease is the second leading cause of death in England, affecting around 6.4 million people.

And a record five million Brits live with diabetes, increasing the risk of strokes, heart attacks and heart failure.

Professor Sir Chris Evans, OBE, founder of EDX Medical, said: “We are extremely excited at the prospect of making the most advanced point-of-care tests available for the benefit of patients everywhere.”

He added: “This is a great collaborative effort between scientists from Oxford and Cambridge.”

“Hutano has the ambition and technology to develop truly unique tests that, when combined with EDX chemistry and smartphone expertise, will create groundbreaking new digital diagnostic products.”

Meanwhile, Dr. Mike Hudson, CEO of EDX Medical: “The group’s combined expertise and resources put us in a unique position to accelerate the introduction of a number of clinically important products and establish a new ‘standard’ in this area.” -of-care -Testing worldwide.’

This comes as supermarket giant Tesco launched a range of home health tests in March, allowing customers to purchase self-diagnosis kits designed to detect the early warning signs of serious conditions such as bowel cancer, kidney disease and even Recognize flu while doing your weekly shopping.

The do-it-yourself checks are available on the company’s website and in more than 500 stores nationwide and use the same technology as the lateral flow devices.

However, experts also warned at the time that the tests could provide “a false sense of security” and even have the potential to “cause direct harm.”

However, in August the National Institute for Health and Care Excellence recommended that DIY testing kits could save 100,000 people each year from having to undergo colonoscopies for suspected bowel cancer.

Last month, researchers at the University of Exeter also announced they had developed a home fingerprint test device that analyzes tiny molecules in the blood to detect health conditions and diseases.

The team expects to complete a similar test for childhood allergies next year and to use the device to check menopause, fertility and healthy aging by 2025.

And they believe it could one day be used to detect early signs of Alzheimer’s or predict a person’s individual risk of developing the devastating disease – for the price of a pregnancy test.

You might also like More from author